Fisher Scientific International Inc.Fisher Scientific International Inc.
2002 Annual ReportLetter to ShareholdersFisher At A GlanceQ & ALeadershipCorporate Information
Beyond ServiceBeyond BoundariesBeyond FulfillmentBeyond TechnologyFinancialsbacknext


Supplementary Information
Selected Financial Data
MD&A
Statement of Operations
Balance Sheet
Statement Of Cash Flows
Statement Of Changes in Stockholders Equity
Notes
Auditors' Report

NOTE 5 FAIR VALUE OF FINANCIAL INSTRUMENTS

The Company’s financial instruments consist primarily of cash held at financial institutions, accounts receivable, debt, interest rate swaps and forward foreign currency contracts.

The carrying amounts for cash and cash equivalents, accounts receivable and short-term debt approximate fair value due to the short-term nature of these instruments. The carrying and fair values of long-term debt were $921.8 million and $959.5 million, respectively, at December 31, 2002 and $956.1 million and $978.6 million, respectively, at December 31, 2001. The fair value of the long-term fixed rate debt was estimated based on current quotes from bond traders making a market in the debt instrument. The fair value of debt with variable rates approximates the net carrying value. As of December 31, 2002, the Company had approximately $12.2 million of outstanding foreign currency forward and option contracts. There were no outstanding forward foreign currency contracts as of December 31, 2001. The fair value of these contracts was insignificant at December 31, 2002. The Company also had off-balance-sheet standby letters of credit with notional amounts of $27.2 million and $54.2 million with no unrealized gain or loss at December 31, 2002 and 2001, respectively.

As of December 31, 2001, the Company was a party to five interest-rate swap agreements in which the Company exchanged its floating-rate obligation on (a) $40.0 million denominated in U.S. dollars for a fixed-rate payment obligation of 5.669 percent per annum through January 21, 2004, (b) $141.9 million denominated in U.S. dollars for a fixed rate obligation of 5.669 percent per annum through December 31, 2003, (c) $22.0 million denominated in British pounds for a fixed-rate payment obligation of 5.850 percent per annum through January 21, 2004, and (d) $7.9 million denominated in Canadian dollars for a fixed-rate payment obligation of 5.6675 percent per annum through January 21, 2004. The notional amount of each interest-rate swap agreement matched the repayment schedule of the Term Facility through the maturity date of the respective interest-rate swap agreements (see Note 13–Debt). The fair values of interest-rate swap agreements are the estimated amounts that the Company would pay or receive to terminate the agreements at the reporting date, taking into account current interest rates, the market expectation for future interest rates and the current creditworthiness of the Company. The fair value of outstanding interest-rate swap agreements as of December 31, 2001, based upon quoted market prices, reflected an unrealized loss of $9.6 million. In April 2002, the Term Facility was repaid in full and the Company recorded a charge in the amount of $7.1 million for fixed-swap unwind costs.

None of the Company’s financial instruments represents a concentration of credit risk as the Company deals with a variety of major banks worldwide, and its accounts receivable are spread among a number of customers and geographic areas.
backnext